Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Melanoma 25Hodgkin Disease 20Lymphoma 9Skin Neoplasms 4Neoplasm Metastasis 4Sarcoma 3Leiomyosarcoma 3Neuroblastoma 2Neoplasms 2Uveal Melanoma 1Skin Diseases 1Sarcoma, Synovial 1Sarcoma, Alveolar Soft Part 1Recurrence 1Melanoma, Cutaneous Malignant 1Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1Liposarcoma 1

Interventions

Doxorubicin 9Ifosfamide 8Radiotherapy 6Neoadjuvant Therapy 3Chemotherapy, Adjuvant 3Trabectedin 2Filgrastim 2Etoposide 2pembrolizumab 1pegfilgrastim 1olaratumab 1milademetan 1indolepropanol phosphate 1brigimadlin 1X-Rays 1Watchful Waiting 1Vincristine 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy, Conformal 1Observation 1Epirubicin 1Diathermy 1Dactinomycin 1Dacarbazine 1Cyproheptadine 1Cyclophosphamide 1Combined Modality Therapy 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Liposarcoma × Dacarbazine × Clear all
NCT01692678 2018-07-11

A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma

Xian-Janssen Pharmaceutical Ltd.

Phase 3 Completed
16 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡